Overview
Clariant is one of the world's leading specialty chemical companies. The company's portfolio is designed to meet very specific needs with as much precision as possible. Its products play an important role in energy efficiency, in the use of renewable raw materials, in emission-free mobility, and in conserving finite resources. Some of its products include catalysts, anti-locking agents, antiwear, binders, dispersing agents, geotextiles, sealants,
...
Read More solvents, detergents, UV filters, and wetting agents, among others. The company's biggest market is EMEA, which accounts for about 40% of revenue. The company was founded in 1995.
Read Less
Read More solvents, detergents, UV filters, and wetting agents, among others. The company's biggest market is EMEA, which accounts for about 40% of revenue. The company was founded in 1995.
Read Less
Conrad Keijzer
See more contacts
Management of Companies and Enterprises
,
Nondepository Credit Intermediation
,
Holding companies, nec
,
Intermediate investment banks
?
?
Actual
$4.71 billion
Actual
-5.14%
82.09%
$6,264
DEC
?
?
Swiss:CLN
Contacts
Get in Touch with 27 Principals*
-
Conrad KeijzerManaging Director and Chairperson
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$4.71 billion
USD
Actual
1 USD = 0.8807 CHF
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $475 | $478 | $570 |
| Net Investing Cash | -$914 | $98 | $175 |
| Net Financing Cash | $315 | -$447 | -$756 |
| Net Change in Cash | -$125 | $128 | -$11 |
| Cash at Beginning of Period | $554 | $447 | $471 |
| Cash at End of Period | $441 | $554 | $447 |
| Capital Expenditure | -$237 | -$235 | -$241 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $441 | $554 | $447 |
| Accounts Receivable | $721 | $644 | $823 |
| Inventories | $737 | $709 | $904 |
| Other Current Assets | $518 | $612 | $856 |
| Asset Summary | |||
| Total Current Assets | $2,416 | $2,518 | $3,031 |
| Tangible Fixed Assets | $1,950 | $1,828 | $2,031 |
| Intangible Assets | $409 | $110 | $144 |
| Total Assets | $6,264 | $5,347 | $6,188 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $847 | $840 | $1,146 |
| Short-Term Debt | $307 | $378 | $403 |
| Other Current Liabilities | $494 | $586 | $565 |
| Liability Summary | |||
| Total Current Liabilities | $1,648 | $1,804 | $2,114 |
| Long-Term Debt | $1,615 | $869 | $988 |
| Other Long-Term Liabilities | $11 | $30 | $62 |
| Total Liabilities | $4,265 | $3,596 | $4,173 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $663 | $822 | $980 |
| Retained Earnings | $3,442 | $3,050 | $3,010 |
| Equity Summary | |||
| Total Equity | $2,651 | $2,291 | $2,658 |
| Shares Outstanding | 328,285,611 | 328,848,494 | 329,016,801 |